IMNM
Price
$9.52
Change
-$0.59 (-5.84%)
Updated
Feb 21 closing price
Capitalization
806.11M
32 days until earnings call
KYMR
Price
$36.81
Change
-$0.61 (-1.63%)
Updated
Feb 21 closing price
Capitalization
2.38B
68 days until earnings call
Ad is loading...

IMNM vs KYMR

Header iconIMNM vs KYMR Comparison
Open Charts IMNM vs KYMRBanner chart's image
Immunome
Price$9.52
Change-$0.59 (-5.84%)
Volume$674.08K
Capitalization806.11M
Kymera Therapeutics
Price$36.81
Change-$0.61 (-1.63%)
Volume$397.35K
Capitalization2.38B
IMNM vs KYMR Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. KYMR commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and KYMR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (IMNM: $10.11 vs. KYMR: $37.42)
Brand notoriety: IMNM and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 52% vs. KYMR: 86%
Market capitalization -- IMNM: $806.11M vs. KYMR: $2.38B
IMNM [@Biotechnology] is valued at $806.11M. KYMR’s [@Biotechnology] market capitalization is $2.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 6 bearish.
  • KYMR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -3.07% price change this week, while KYMR (@Biotechnology) price change was +2.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

IMNM is expected to report earnings on May 08, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.38B) has a higher market cap than IMNM($806M). IMNM YTD gains are higher at: -4.802 vs. KYMR (-6.985). IMNM has higher annual earnings (EBITDA): -109.95M vs. KYMR (-160.96M). KYMR has more cash in the bank: 550M vs. IMNM (240M). IMNM has less debt than KYMR: IMNM (2.72M) vs KYMR (88.2M). KYMR has higher revenues than IMNM: KYMR (87.6M) vs IMNM (10.1M).
IMNMKYMRIMNM / KYMR
Capitalization806M2.38B34%
EBITDA-109.95M-160.96M68%
Gain YTD-4.802-6.98569%
P/E RatioN/AN/A-
Revenue10.1M87.6M12%
Total Cash240M550M44%
Total Debt2.72M88.2M3%
TECHNICAL ANALYSIS
Technical Analysis
IMNMKYMR
RSI
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 5 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEGRX72.480.18
+0.25%
First Eagle Global R6
FTIEX12.33N/A
N/A
Fidelity Total International Equity
SMDVX18.68N/A
N/A
Hartford Schroders US MidCap Opps A
NDVTX18.41N/A
N/A
MFS New Discovery Value R3
GIZFX12.56N/A
N/A
Invesco Global Infrastructure R5

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+2.12%
KYMR - IMNM
49%
Loosely correlated
-0.61%
IDYA - IMNM
49%
Loosely correlated
+5.18%
FATE - IMNM
48%
Loosely correlated
-9.65%
BEAM - IMNM
47%
Loosely correlated
-2.79%
CCCC - IMNM
47%
Loosely correlated
-0.66%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.61%
CCCC - KYMR
60%
Loosely correlated
-0.66%
IMNM - KYMR
49%
Loosely correlated
+2.12%
ERAS - KYMR
48%
Loosely correlated
-3.31%
ATXS - KYMR
48%
Loosely correlated
-2.57%
ACLX - KYMR
47%
Loosely correlated
+3.67%
More